Format

Send to

Choose Destination
Am J Cardiol. 1996 May 1;77(11):1017-20.

Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry.

Author information

1
University of Medicine and Dentistry-Robert Wood Johnson Medical School, New Brunswick, New Jersey 08903-0019, USA.

Abstract

Diabetes is an independent predictor of morbidity and mortality in patients with symptomatic heart failure, patients with asymptomatic left ventricular dysfunction (defined as an ejection fraction of 35% or less), and in a broader registry population with less stringent entry criteria. Although the SOLVD Trials made a major clinical contribution by proving the value of enalapril, diabetes remains a significant predictor of outcome even after adjusting for treatment with enalapril.

PMID:
8644628
DOI:
10.1016/s0002-9149(97)89163-1
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center